🌐 World · English ▾
Current: 🌐 World · English
Global
Focused
Language
Thursday 29 October
🌐 World · English ▾
Current: 🌐 World · English
Global
Focused
Language

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

What to know

  • The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.S1
  • Novo shares fell as much as 7% on Monday after the company laid out new growth ambitions to revive itsS2
Timeline · newest first
1mo Cnbc

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.

1mo Wol

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

Novo shares fell as much as 7% on Monday after the company laid out new growth ambitions to revive its

Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs

2 outlets 2 reports

What to know

  • The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.S1
  • Novo shares fell as much as 7% on Monday after the company laid out new growth ambitions to revive itsS2
Timeline · newest first

Sources · 2 citations

S1 Cnbc 1 report · EN
S2 WolLead 1 report · EN